Trinity Biotech reported $41.9M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 171.01B 12.96B Sep/2026
Bayer EUR 52.42B 5.31B Nov/2026
Bio-Rad Laboratories USD 8.71B 840M Nov/2026
EDAP TMS EUR 139M 66M Mar/2026
J&J USD 653.61B 42.25B Sep/2026
OraSure Technologies USD 174M 61M Dec/2025
Plus Therapeutics USD 1000K 70M Mar/2026
Roche Holding CHF 270B 3.66B Jun/2026
Siemens EUR 218.02B 2.58B Nov/2026
Thermo Fisher Scientific USD 249.58B 58.93B Sep/2026
Tosoh JPY 738.31B 116.66B Nov/2026
Trinity Biotech USD 315M 300M Mar/2026
Veracyte USD 4.12B 414M Nov/2026